Urinary kallikrein in normotensive subjects and in patients with essential hypertension. 1979

H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff

1. Excretion of urinary kallikrein was normal in 13 out of 15 patients with uncomplicated essential hypertension. 2. Frusemide increased urinary kallikrein excretion in normotensive subjects and in patients with essential hypertension. The stimulating effect of frusemide on urinary kallikrein was significantly diminished in patients with essential hypertension. 3. No correlations of urinary kallikrein with sodium, potassium, and aldosterone excretion were found. 4. The results do not support the idea that urinary kallikrein plays a primary role in the pathogenesis of essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008297 Male Males
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer

Related Publications

H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
May 1981, The Journal of clinical endocrinology and metabolism,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
August 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
January 1979, Minerva nefrologica,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
September 1981, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
April 1995, Circulation,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
December 1979, Clinical science (London, England : 1979),
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
November 1977, Circulation,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
February 1980, The Journal of clinical investigation,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
April 1992, Nihon rinsho. Japanese journal of clinical medicine,
H Zschiedrich, and P Fleckenstein, and R Geiger, and E Fink, and K Sinterhauf, and T Philipp, and A Distler, and H P Wolff
March 1978, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!